Clinical utility of QuantiFERON TB Gold Test in the diagnosis of latent tuberculosis infections


Submitted: 14 February 2014
Accepted: 14 February 2014
Published: 31 March 2010
Abstract Views: 765
PDF: 797
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Introduction: Early diagnosis of latent tuberculosis infection can avoid a progression to active tuberculosis.The interferon gamma (IFN-γ) production measured by the new interferon-gamma release assays (IGRAs) can be used to identify subjects with, because the tuberculin skin test, is unreliable to discriminative between subjects with and others. Methods: 186 patients tested positive with the tuberculin skin test were evaluated with QuantiFERON- TB Gold [QFT-G (Cellestis Ltd, Carnegie, Australia)]. Results: 61 (32.8%) samples showed a positive response with QFT-G test and only 1 (0.54%) patient tested indeterminate. Conclusion: These preliminary data suggest that QFT-G-positivity showed a strong correlation with clinical suspect of latent tuberculosis infection.

Nisticò, S., Potente, G. I., Cerminara, M. T., Scuro, L., & Luciano, A. (2010). Clinical utility of QuantiFERON TB Gold Test in the diagnosis of latent tuberculosis infections. Microbiologia Medica, 25(1). https://doi.org/10.4081/mm.2010.2473

Downloads

Download data is not yet available.

Citations


Similar Articles

You may also start an advanced similarity search for this article.